UC San Diego ranks 9th globally (tied with The Max Planck Society for the Advancement of Science, Germany's premier, non-university research organization dedicated ...
Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.
A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the effectiveness of the drug.